Corrigendum to "Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPα)" [Biochem. Biophys. Res. Commun. 346 (2006) 436-446] (DOI:10.1016/j.bbrc.2006.05.175);Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPα)

Biochemical and Biophysical Research Communications

Volumn 346, Issue 2, 2006, Pages 436-446

  Gilmore, Brendan F ^a   Lynas, John F ^a   Scott, Christopher J ^a   McGoohan, Caroline ^a   Martin, Lorraine ^a   Walker, Brian ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Diphenyl phosphonate esters; DPP IV; LOX; Melanoma; Post proline dipeptidyl peptidase; Seprase; Serine protease

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PHOSPHONIC ACID DERIVATIVE; PROLINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SYNTHESIS;

EID: 33745171752     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.086     Document Type: Erratum

References (42)

1. Aoyama A., and Chen W.-T. A 170-kDa membrane-bound protease associated with the expression of invasiveness by human malignant melanoma cells. Proc. Natl. Acad. Sci. USA 87 (1990) 8296-8300
2. Pineiro-Sanchez M.L., Goldstein L.A., Dodt J., Howard L., Yeh Y., Tran H., Argraves W.S., and Chen W.-T. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J. Biol. Chem. 272 (1997) 7595-7601
3. Goldstein L.A., Ghersi G., Piñeiro-Sanchez M.L., Salamone M., Yeh Y., Flessate D., and Chen W.T. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim. Biophys. Acta 1361 (1997) 11-19
4. Monsky W.L., Lin C.V., Aoyama A., Kelly T., and Akiyama S.K. A potential protease marker of invasiveness, seprase, is localised on invadopodia of human malignant melanoma-cells. Cancer Res. 54 (1994) 5702-5710
5. Kelly T., Kechelava S., Rozypal T.L., West K.W., and Korourian S. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod. Pathol. 11 (1998) 855-863
6. Kelly T., Mueller S.C., Yeh Y., and Chen W.-T. Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell. Physiol. 158 (1994) 299-308
7. Okada K., Chen W.T., Iwasa S., Jin X., Yamane T., Ooi A., and Mitsumata M. Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology 65 (2003) 363-370
8. Mori Y., Kono K., Matsumoto Y., Fujii H., Yamane T., Mitsumata M., and Chen W.T. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology 67 5-6 (2004) 411-419
9. Rennex D., Hemmings B.A., Hofsteenge J., and Stone S.R. cDNA cloning of porcine brain prolyl endopeptidase and identification of the active-site seryl residue. Biochemistry 30 (1991) 2195-2203
10. Polgar L., and Szabo E. Prolyl endopeptidase and dipeptidyl peptidase IV are distantly related members of the same family of serine proteases. Biol. Chem. Hoppe Seyler 373 (1992) 361-366
11. Barrett A.J., and Rawlings N.D. Oligopeptidases, and the emergence of the prolyl oligopeptidase family. Biol. Chem. Hoppe Seyler 373 (1992) 353-360
12. Polgar L. The prolyl oligopeptidase family. Cell. Mol. Life Sci. 59 (2002) 349-362
13. Monsky W.L., and Chen W.T. Proteases of cell adhesion proteins in cancer. Semin. Cancer Biol. 4 (1993) 251-258
14. Kelly T. Evaluation of seprase activity. Clin. Exp. Metastasis 17 (1999) 57-62
15. Levy M.T., McCaughan G.W., Marinos G., and Gorrell M.D. Chronic hepatitis C: fibroblast activation protein expression correlates with hepatic fibrosis. Hepatology 30 (1999) 323A
16. Park J.E., Lenter M.C., Zimmermann R.N., Garin-Chesa P., Old L.J., and Rettig W.J. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274 (1999) 36505-36512
17. Ghersi G., Dong H., Goldstein L.A., Yeh Y.-Y., Hakkinen L., Larjava H.S., and Chen W.-T. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J. Biol. Chem. 277 (2002) 29231-29241
18. Chen W.-T., Kelly T., and Ghersi G. DPPIV, seprase, and related serine peptidases in multiple cellular functions. Curr. Top. Dev. Biol. 54 (2003) 207-232
19. Boduszek B., Oleksyszyn J., Kam C.M., Selzler J., Smith R.E., and Powers J.C. Dipeptide phosphonates as inhibitors of dipeptidyl peptidase IV. J. Med. Chem. 37 (1994) 3969-3976
20. Belyaev A., Zhang A., Augustyns K., Lambeir A.-M., De Meester I., Vedernikova I., Scharpé S., and Haemers A. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J. Med. Chem. 42 (1999) 1041-1052
21. Nomura Y., Ogawa K., Takeuchi Y., and Tomoda S. One-step synthesis and structural confirmation of 1-pyrroline trimer. Chem. Lett. (Japan) 1977 (1977) 693-696
22. Fodstad Ø., Aamdal S., McMenamin M., Nesland J.M., and Pihl A. A new experimental metastasis model in athymic nude mice, the human melanoma LOX. Int. J. Cancer 41 (1988) 442-449
23. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256 (1981) 1604-1607
24. Huang Y., Wang S., and Kelly T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 64 (2004) 2712-2716
25. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., and McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumour cells. Cancer Res. 47 (1987) 3239-3245
26. Tian W.-X., and Tsou C.-L. Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry 21 (1982) 1028-1032
27. Walker B., and Elmore D.T. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl) carbamoylimidazole. Biochem. J. 221 (1984) 277-280
28. Duggleby R.G., Attwood P.V., Wallace J.C., and Keech D.B. Avidin is a slow-binding inhibitor of pyruvate-carboxylase. Biochemistry 21 (1982) 3364-3370
29. Mentlein R. Dipeptidyl peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul. Pept. 85 (1999) 9-24
30. Wrenger S., Kahne T., Bohuon C., Weglohner W., Ansorge S., and Reinhold D. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). FEBS Lett. 466 (2000) 155-159
31. Nausch I., Mentlein R., and Heymann E. The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol. Chem. Hoppe Seyler 371 (1990) 1113-1118
32. Hoffmann T., Faust J., Neubert K., and Ansorge S. Dipeptidyl peptidase IV (CD26) and aminopeptidase N (CD13) catalysed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 336 (1993) 61-64
33. Yaron A., and Naider F. Proline-dependant structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28 (1993) 31-81
34. Mentlein R., Dahms P., Grandt D., and Kruger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Pept. 49 (1993) 133-144
35. Oravecz T., Pall M., Roderiquez G., Gorrell M.D., Ditto M., Nguyen N.Y., Boykins R., Unsworth E., and Norcross M.A. Regulation of the recetor specificity and function of the chemokine RANTES (Regulated on Activation, Normal T cell Expressed and Secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186 (1997) 1865-1872
36. Proost P., De Meester I., Schols D., Struyf S., Lambier A.-M., Wuyts A., Opdenakker G., De Clercq E., Scharpé S., and Van Damme J. Amino-terminal truncation of chemokines by CD26/Dipeptidyl peptidase IV: conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1 infection. J. Biol. Chem. 273 (1998) 7222-7227
37. Liotta L.A., Thorgeirsson U.P., and Garbisa S. Role of collagenases in tumour cell invasion. Cancer Metastasis Rev. 1 (1982) 277-288
38. Danø K., Andreasen P.A., Grøndahl-Hansen J., Kristensen P., Nielson L.S., and Skriver L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44 (1985) 139-266
39. Schmitt M., Jänicke F., and Graeff H. Tumor-associated proteases. Fibrinolysis 6 S4 (1992) 3-36
40. Del Rosso M., Fibbi G., Pucci M., D'Alessio S., Del Rosso A., Magnelli L., and Chiarugi V. Multiple pathways of cell invasion are regulated by multiple pathways of serine proteases. Clin. Exp. Metastasis 19 (2002) 193-207
41. Aertgeerts K., Levin I., Shi L., Snell G.P., Jennings A., Prasad G.S., Zhang Y., Kraus M.L., Salakian S., Sridhar V., Wijnands R., and Tennant M.G. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α. J. Biol. Chem. 280 (2005) 19441-19444
42. Edosada C.Y., Quan C., Wiesmann C., Tran T., Sutherlin D., Reynolds M., Elliott J.M., Raab H., Fairbrother W., and Wolf B.B. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J. Biol. Chem. 281 (2006) 7437-7444